These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 30814001)

  • 1. A Bio-Inspired Amplification Cascade for the Detection of Rare Cancer Cells.
    Rüegg C; Reis C; Rafiee S; Rodriguez-Lorenzo L; List J; Rothen-Rutishauser B; Mayer M; Petri-Fink A
    Chimia (Aarau); 2019 Feb; 73(1-2):63-68. PubMed ID: 30814001
    [No Abstract]   [Full Text] [Related]  

  • 2. The prognostic and therapeutic implications of circulating tumor cell phenotype detection based on epithelial-mesenchymal transition markers in the first-line chemotherapy of HER2-negative metastatic breast cancer.
    Guan X; Ma F; Li C; Wu S; Hu S; Huang J; Sun X; Wang J; Luo Y; Cai R; Fan Y; Li Q; Chen S; Zhang P; Li Q; Xu B
    Cancer Commun (Lond); 2019 Jan; 39(1):1. PubMed ID: 30606259
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genome‑wide copy number analysis of circulating tumor cells in breast cancer patients with liver metastasis.
    Zou L; Imani S; Maghsoudloo M; Shasaltaneh MD; Gao L; Zhou J; Wen Q; Liu S; Zhang L; Chen G
    Oncol Rep; 2020 Sep; 44(3):1075-1093. PubMed ID: 32705227
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Relevance of CTC Clusters in Breast Cancer Metastasis.
    Piñeiro R; Martínez-Pena I; López-López R
    Adv Exp Med Biol; 2020; 1220():93-115. PubMed ID: 32304082
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic impact of circulating tumor cell apoptosis and clusters in serial blood samples from patients with metastatic breast cancer in a prospective observational cohort.
    Jansson S; Bendahl PO; Larsson AM; Aaltonen KE; Rydén L
    BMC Cancer; 2016 Jul; 16():433. PubMed ID: 27390845
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Enhanced Isolation and Release of Circulating Tumor Cells Using Nanoparticle Binding and Ligand Exchange in a Microfluidic Chip.
    Park MH; Reátegui E; Li W; Tessier SN; Wong KH; Jensen AE; Thapar V; Ting D; Toner M; Stott SL; Hammond PT
    J Am Chem Soc; 2017 Feb; 139(7):2741-2749. PubMed ID: 28133963
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Circulating tumor cells as Trojan Horse for understanding, preventing, and treating cancer: a critical appraisal.
    Mentis AA; Grivas PD; Dardiotis E; Romas NA; Papavassiliou AG
    Cell Mol Life Sci; 2020 Sep; 77(18):3671-3690. PubMed ID: 32333084
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Detection of HER2
    Rafiee SD; Kocabey S; Mayer M; List J; Rüegg C
    ChemMedChem; 2020 Apr; 15(8):661-666. PubMed ID: 31943804
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunomagnetic Capture and Multiplexed Surface Marker Detection of Circulating Tumor Cells with Magnetic Multicolor Surface-Enhanced Raman Scattering Nanotags.
    Wilson RE; O'Connor R; Gallops CE; Kwizera EA; Noroozi B; Morshed BI; Wang Y; Huang X
    ACS Appl Mater Interfaces; 2020 Oct; 12(42):47220-47232. PubMed ID: 32966038
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Circulating tumor cells in breast cancer: detection systems, molecular characterization, and future challenges.
    Lianidou ES; Markou A
    Clin Chem; 2011 Sep; 57(9):1242-55. PubMed ID: 21784769
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Detection of Circulating Tumor Cells in Breast Cancer Patients Using Cytokeratin-19 Real-Time RT-PCR.
    Park HS; Han HJ; Lee S; Kim GM; Park S; Choi YA; Lee JD; Kim GM; Sohn J; Kim SI
    Yonsei Med J; 2017 Jan; 58(1):19-26. PubMed ID: 27873491
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Circulating levels of transforming growth factor-βeta (TGF-β) and chemokine (C-X-C motif) ligand-1 (CXCL1) as predictors of distant seeding of circulating tumor cells in patients with metastatic breast cancer.
    Divella R; Daniele A; Savino E; Palma F; Bellizzi A; Giotta F; Simone G; Lioce M; Quaranta M; Paradiso A; Mazzocca A
    Anticancer Res; 2013 Apr; 33(4):1491-7. PubMed ID: 23564790
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gold Nanoparticle-Based Microfluidic Chips for Capture and Detection of Circulating Tumor Cells.
    Pedrosa VA; Chen K; George TJ; Fan ZH
    Biosensors (Basel); 2023 Jul; 13(7):. PubMed ID: 37504105
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Incorporating MicroRNA into Molecular Phenotypes of Circulating Tumor Cells Enhances the Prognostic Accuracy for Patients with Metastatic Breast Cancer.
    Tan W; Liang G; Xie X; Jiang W; Tan L; Sanders AJ; Liu Z; Ling Y; Zhong W; Tian Z; Lin W; Gong C
    Oncologist; 2019 Nov; 24(11):e1044-e1054. PubMed ID: 31300482
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic relevance of the HER2 status of circulating tumor cells in metastatic breast cancer patients screened for participation in the DETECT study program.
    Müller V; Banys-Paluchowski M; Friedl TWP; Fasching PA; Schneeweiss A; Hartkopf A; Wallwiener D; Rack B; Meier-Stiegen F; Huober J; Rübner M; Hoffmann O; Müller L; Janni W; Wimberger P; Jäger B; Pantel K; Riethdorf S; Harbeck N; Fehm T;
    ESMO Open; 2021 Dec; 6(6):100299. PubMed ID: 34839105
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Introduction - Biology of Breast Cancer Metastasis and Importance of the Analysis of CTCs.
    Piñeiro R
    Adv Exp Med Biol; 2020; 1220():1-10. PubMed ID: 32304076
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Disseminated tumor cells in bone marrow and circulating tumor cells in blood of breast cancer patients: current state of detection and characterization.
    Riethdorf S; Pantel K
    Pathobiology; 2008; 75(2):140-8. PubMed ID: 18544969
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Longitudinal enumeration and cluster evaluation of circulating tumor cells improve prognostication for patients with newly diagnosed metastatic breast cancer in a prospective observational trial.
    Larsson AM; Jansson S; Bendahl PO; Levin Tykjaer Jörgensen C; Loman N; Graffman C; Lundgren L; Aaltonen K; Rydén L
    Breast Cancer Res; 2018 Jun; 20(1):48. PubMed ID: 29884204
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Single cell mutational analysis of PIK3CA in circulating tumor cells and metastases in breast cancer reveals heterogeneity, discordance, and mutation persistence in cultured disseminated tumor cells from bone marrow.
    Deng G; Krishnakumar S; Powell AA; Zhang H; Mindrinos MN; Telli ML; Davis RW; Jeffrey SS
    BMC Cancer; 2014 Jun; 14():456. PubMed ID: 24947048
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Circulating and disseminated tumor cells from breast cancer patient-derived xenograft-bearing mice as a novel model to study metastasis.
    Giuliano M; Herrera S; Christiny P; Shaw C; Creighton CJ; Mitchell T; Bhat R; Zhang X; Mao S; Dobrolecki LE; Al-rawi A; Chen F; Veneziani BM; Zhang XH; Hilsenbeck SG; Contreras A; Gutierrez C; Jeselsohn RM; Rimawi MF; Osborne CK; Lewis MT; Schiff R; Trivedi MV
    Breast Cancer Res; 2015 Jan; 17(1):3. PubMed ID: 25572662
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.